150 related articles for article (PubMed ID: 18821571)
1. The Fourth International Peptide Symposium: discovery to drugs: the peptide pipeline.
Benson H; Toth I
Biopolymers; 2008; 90(5):588. PubMed ID: 18821571
[No Abstract] [Full Text] [Related]
2. Genomics and proteomics tools for compound mode-of-action studies in drug discovery.
Kley N; Ivanov I; Meier-Ewert S
Pharmacogenomics; 2004 Jun; 5(4):395-404. PubMed ID: 15165175
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic peptides: technological advances driving peptides into development.
Sato AK; Viswanathan M; Kent RB; Wood CR
Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
[TBL] [Abstract][Full Text] [Related]
4. [Ligandomics--a tool for the development of targeted treatments].
Porkka K; Laakkonen P
Duodecim; 2002; 118(11):1185-92. PubMed ID: 12239852
[No Abstract] [Full Text] [Related]
5. Peptide revolution: genomics, proteomics and therapeutics.
Sawyer TK; Chorev M
Biotechniques; 2003 Mar; 34(3):594-6, 598-9. PubMed ID: 12661163
[No Abstract] [Full Text] [Related]
6. Discovery to drugs: the peptide pipeline. Proceedings of the Fourth International Peptide Symposium. Fall 2007. Cairns, Australia.
Biopolymers; 2008; 90(5):587-670. PubMed ID: 18821570
[No Abstract] [Full Text] [Related]
7. The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets.
Bodovitz S; Joos T
Trends Biotechnol; 2004 Jan; 22(1):4-7. PubMed ID: 14690616
[No Abstract] [Full Text] [Related]
8. Identification of anti-infective targets through comparative proteomics.
Burchmore R
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):163-5. PubMed ID: 16597196
[No Abstract] [Full Text] [Related]
9. Application of proteomics in biotechnology--microbial proteomics.
Josic D; Kovac S
Biotechnol J; 2008 Apr; 3(4):496-509. PubMed ID: 18320565
[TBL] [Abstract][Full Text] [Related]
10. Membrane permeable peptide vectors: chemistry and functional design for the therapeutic applications.
Futaki S
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):447. PubMed ID: 18077052
[No Abstract] [Full Text] [Related]
11. Application of LC/MS to proteomics studies: current status and future prospects.
Chen G; Pramanik BN
Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
[TBL] [Abstract][Full Text] [Related]
12. The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy.
Lotze MT
Curr Opin Investig Drugs; 2003 Jun; 4(6):649-51. PubMed ID: 12901221
[No Abstract] [Full Text] [Related]
13. Your health in the 21st century. The science of drugs.
Ulick J; Golan D
Newsweek; 2005; 145(26A):suppl 6 p. following 44. PubMed ID: 16422014
[No Abstract] [Full Text] [Related]
14. Biophysical delivery of peptides: applicability for cancer therapy.
Dass CR; Choong PF
Peptides; 2006 Dec; 27(12):3479-88. PubMed ID: 16996648
[TBL] [Abstract][Full Text] [Related]
15. Impact of proteomics on bladder cancer research.
Celis JE; Gromova I; Moreira JM; Cabezon T; Gromov P
Pharmacogenomics; 2004 Jun; 5(4):381-94. PubMed ID: 15165174
[TBL] [Abstract][Full Text] [Related]
16. The 14th International Symposium on Recent Advances in Drug Delivery Systems, February 15-18, 2009, Salt Lake City, UT, USA.
Park K; Bae YH; Grainger DW
J Control Release; 2009 Dec; 140(3):183-4. PubMed ID: 19751779
[No Abstract] [Full Text] [Related]
17. Drugs, past, present, and future.
Kaye AD
Curr Opin Anaesthesiol; 2008 Aug; 21(4):425-6. PubMed ID: 18660646
[No Abstract] [Full Text] [Related]
18. 4th International Peptide Symposium in conjunction with the 7th Australian Peptide Symposium and the 2nd Asia-Pacific International Peptide Symposium.
Nice EC
Expert Rev Proteomics; 2007 Dec; 4(6):705-7. PubMed ID: 18067409
[No Abstract] [Full Text] [Related]
19. Drug Delivery Systems--9th US-Japan symposium.
Uhland S
IDrugs; 2008 Mar; 11(3):186-8. PubMed ID: 18311655
[No Abstract] [Full Text] [Related]
20. Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.
Sawyer TK
Chem Biol Drug Des; 2006 Mar; 67(3):196-200. PubMed ID: 16611212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
